Seeking Alpha

Switzerland has become the first European county to approve Pfizer's (PFE) Tofacitinib treatment...

Switzerland has become the first European county to approve Pfizer's (PFE) Tofacitinib treatment for rheumatoid arthritis, which can be used in patients who haven't responded well enough to existing treatments. Tofacitinib has also been authorized in Argentina, Kuwait, the UAE and Russia. The approvals add to those in the U.S. and Japan, where Pfizer plans to launch Tofacitinib with Takeda Pharmaceutical this month. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|